These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 22053918)
1. The relation of serotonin-related gene and COMT gene polymorphisms with criminal behavior in schizophrenic disorder. Koh KB; Choi EH; Lee YJ; Han M; Choi SS; Kim SW; Lee MG J Clin Psychiatry; 2012 Feb; 73(2):159-63. PubMed ID: 22053918 [TBL] [Abstract][Full Text] [Related]
2. Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women. Sazci A; Ergul E; Kucukali I; Kilic G; Kaya G; Kara I Brain Res Mol Brain Res; 2004 Dec; 132(1):51-6. PubMed ID: 15548428 [TBL] [Abstract][Full Text] [Related]
3. Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol O-methyltransferase (COMT) activity. Kotler M; Barak P; Cohen H; Averbuch IE; Grinshpoon A; Gritsenko I; Nemanov L; Ebstein RP Am J Med Genet; 1999 Dec; 88(6):628-33. PubMed ID: 10581481 [TBL] [Abstract][Full Text] [Related]
4. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study. Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207 [TBL] [Abstract][Full Text] [Related]
5. Serotonin-related gene pathways associated with undifferentiated somatoform disorder. Koh KB; Choi EH; Lee YJ; Han M Psychiatry Res; 2011 Sep; 189(2):246-50. PubMed ID: 21531467 [TBL] [Abstract][Full Text] [Related]
6. The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia. Ohnishi T; Hashimoto R; Mori T; Nemoto K; Moriguchi Y; Iida H; Noguchi H; Nakabayashi T; Hori H; Ohmori M; Tsukue R; Anami K; Hirabayashi N; Harada S; Arima K; Saitoh O; Kunugi H Brain; 2006 Feb; 129(Pt 2):399-410. PubMed ID: 16330500 [TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in catechol-O-methyltransferase and methylenetetrahydrofolate reductase in relation to the risk of schizophrenia. Muntjewerff JW; Gellekink H; den Heijer M; Hoogendoorn ML; Kahn RS; Sinke RJ; Blom HJ Eur Neuropsychopharmacol; 2008 Feb; 18(2):99-106. PubMed ID: 17716874 [TBL] [Abstract][Full Text] [Related]
8. Genetic variation in COMT and PRODH is associated with brain anatomy in patients with schizophrenia. Zinkstok J; Schmitz N; van Amelsvoort T; Moeton M; Baas F; Linszen D Genes Brain Behav; 2008 Feb; 7(1):61-9. PubMed ID: 17504246 [TBL] [Abstract][Full Text] [Related]
9. COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance. Burdick KE; Funke B; Goldberg JF; Bates JA; Jaeger J; Kucherlapati R; Malhotra AK Bipolar Disord; 2007 Jun; 9(4):370-6. PubMed ID: 17547583 [TBL] [Abstract][Full Text] [Related]
10. Catechol-O-methyltransferase val108/158met genotype and response to antipsychotic medication in schizophrenia. Illi A; Kampman O; Hänninen K; Anttila S; Mattila KM; Katila H; Rontu R; Hurme M; Lehtimäki T; Leinonen E Hum Psychopharmacol; 2007 Jun; 22(4):211-5. PubMed ID: 17526059 [TBL] [Abstract][Full Text] [Related]
11. Identification of a BglI polymorphism of catechol-O-methyltransferase (COMT) gene, and association study with schizophrenia. Chen CH; Lee YR; Liu MY; Wei FC; Koong FJ; Hwu HG; Hsiao KJ Am J Med Genet; 1996 Nov; 67(6):556-9. PubMed ID: 8950414 [TBL] [Abstract][Full Text] [Related]
12. Investigation of A218C tryptophan hydroxylase polymorphism: association with familial suicide behavior and proband's suicide attempt characteristics. Viana MM; De Marco LA; Boson WL; Romano-Silva MA; Corrêa H Genes Brain Behav; 2006 Jun; 5(4):340-5. PubMed ID: 16716203 [TBL] [Abstract][Full Text] [Related]
13. Schizophrenia and functional polymorphisms in the MAOA and COMT genes: no evidence for association or epistasis. Norton N; Kirov G; Zammit S; Jones G; Jones S; Owen R; Krawczak M; Williams NM; O'Donovan MC; Owen MJ Am J Med Genet; 2002 Jul; 114(5):491-6. PubMed ID: 12116182 [TBL] [Abstract][Full Text] [Related]
14. Analysis of an association between the COMT polymorphism and clinical symptomatology in schizophrenia. Strous RD; Lapidus R; Viglin D; Kotler M; Lachman HM Neurosci Lett; 2006 Jan; 393(2-3):170-3. PubMed ID: 16233957 [TBL] [Abstract][Full Text] [Related]
15. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Goldberg TE; Egan MF; Gscheidle T; Coppola R; Weickert T; Kolachana BS; Goldman D; Weinberger DR Arch Gen Psychiatry; 2003 Sep; 60(9):889-96. PubMed ID: 12963670 [TBL] [Abstract][Full Text] [Related]
16. Catechol-O-methyltransferase Val158Met polymorphism in relation to aggressive schizophrenia in a Korean population. Kim YR; Kim JH; Kim SJ; Lee D; Min SK Eur Neuropsychopharmacol; 2008 Nov; 18(11):820-5. PubMed ID: 18789857 [TBL] [Abstract][Full Text] [Related]
17. Dopaminergic pathway gene polymorphisms and genetic susceptibility to schizophrenia among north Indians. Srivastava V; Deshpande SN; Thelma BK Neuropsychobiology; 2010; 61(2):64-70. PubMed ID: 20016224 [TBL] [Abstract][Full Text] [Related]
18. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment. Molero P; Ortuño F; Zalacain M; Patiño-García A Pharmacogenomics J; 2007 Dec; 7(6):418-26. PubMed ID: 17363961 [TBL] [Abstract][Full Text] [Related]
19. Effects of brain-derived neurotrophic factor-catecholamine-O-methyltransferase gene interaction on schizophrenic symptoms. Han DH; Park DB; Choi TY; Joo SY; Lee MK; Park BR; Nishimura R; Chu CC; Renshaw PF Neuroreport; 2008 Jul; 19(11):1155-8. PubMed ID: 18596619 [TBL] [Abstract][Full Text] [Related]
20. Catechol-O-methyltransferase genotype is associated with plasma total homocysteine levels and may increase venous thrombosis risk. Gellekink H; Muntjewerff JW; Vermeulen SH; Hermus AR; Blom HJ; den Heijer M Thromb Haemost; 2007 Dec; 98(6):1226-31. PubMed ID: 18064318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]